Your browser doesn't support javascript.
loading
Fibroblast activation in response to TGFß1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform.
Luu, Rebeccah J; Hoefler, B Christopher; Gard, Ashley L; Ritenour, Casey R; Rogers, Miles T; Kim, Ernest S; Coppeta, Jonathan R; Cain, Brian P; Isenberg, Brett C; Azizgolshani, Hesham; Fajardo-Ramirez, Oscar R; García-Cardeña, Guillermo; Lech, Matthew P; Tomlinson, Lindsay; Charest, Joseph L; Williams, Corin.
Afiliação
  • Luu RJ; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Hoefler BC; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Gard AL; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Ritenour CR; Pfizer Inc., Groton, CT, United States.
  • Rogers MT; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Kim ES; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Coppeta JR; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Cain BP; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Isenberg BC; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Azizgolshani H; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Fajardo-Ramirez OR; Laboratory for Systems Mechanobiology, Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • García-Cardeña G; Laboratory for Systems Mechanobiology, Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • Lech MP; Pfizer Inc., Cambridge, MA, United States.
  • Tomlinson L; Pfizer Inc., Cambridge, MA, United States.
  • Charest JL; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
  • Williams C; Bioengineering Division, The Charles Stark Draper Laboratory Inc., Cambridge, MA, United States.
Front Mol Biosci ; 10: 1160851, 2023.
Article em En | MEDLINE | ID: mdl-37577751

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article